NCCIH Featured Content


12/07/2017 11:09 AM
Hello From NCCIH's New Leadership Team

Hello from NCCIH’s new leadership team! In this message, Acting Director David Shurtleff and Acting Deputy Director Wendy Weber introduce themselves and highlight NCCIH’s research interests and resources.


12/07/2017 09:07 AM
Study Identifies a Novel Mechanism by Which Cells May Detect a Variety of Sensations
Piezo2

Study build on earlier NCCIH-funded research on the Piezo2 protein and Piezo2 gene (the gene guides the production of different forms of the protein, which may play roles in distinguishing sensations).


12/01/2017 09:37 AM
Grant Funding Available for Behavioral Interventions for Prevention of Opioid Use Disorder and as an Adjunct to Medication-Assisted Treatment

In this research blog, Drs. Robin Boineau (NCCIH) and Kimberly Johnson (SAMHSA) discuss a new funding initiative to examine the impact of behavioral interventions for opioid addiction within the context of states’ plans for use of Opioid STR grant funds.


12/01/2017 09:30 AM
Complementary Health Approaches for Travelers
Boarding a plane

Do any complementary health approaches help for travel-related health issues? Find out here.


11/27/2017 01:44 PM
Internet Marketers of Dietary Supplement and Skincare Products Banned from Deceptive Advertising and Billing Practices

A network of online marketers and the three people behind it have settled FTC charges that they sold weight-loss, muscle-building, and wrinkle-reduction products to consumers using unsubstantiated health claims, fake magazine and news sites, bogus celebrity endorsements, and phony consumer testimonials.


11/27/2017 11:44 AM
Leaving the Center in Good Hands

In this blog post, Dr. Josephine Briggs reviews her time as Director of NCCIH and discusses the Center’s focus on pain research.


11/22/2017 07:30 AM
Florida-based Supplement Sellers Settle FTC False Advertising Charges

NextGen Nutritionals, Strictly Health, and Cyber Business Technology, and owners Anna McLean and Robert McLean have settled Federal Trade Commission charges that they deceptively marketed and sold dietary supplements.


11/21/2017 01:56 PM
Variations in the Types and Amounts of Bacteria in Echinacea Plants May Influence the Herb’s Effects on Infectious Disease
Echinacea

Differences in the bacteria inside echinacea plants may determine whether and how much the herb enhances the immune system and fights infectious diseases like the common cold.


11/21/2017 01:45 PM
Building the Understanding of the Effects of Tai Chi Training on Walking in Older People
Tai Chi

Tai chi may help older people who have problems with walking (and falling).


11/15/2017 12:46 PM
Statement from FDA Commissioner Scott Gottlieb, M.D. on FDA advisory about deadly risks associated with kratom

FDA issues statement on kratom, voices safety concerns.


11/14/2017 11:22 AM
The NIH Collaboratory Launches a New Resource on Methods and Best Practices for Pragmatic Clinical Trials

In this blog post, Dr. Catherine Meyers discusses The Living Textbook, a researcher-friendly compendium of information for designing, planning, and implementing pragmatic clinical trials.


11/09/2017 09:17 AM
Ridge Properties DBA Pain Relief Naturally Issues Voluntary Nationwide Recall of all lots of Naturally HL Bedsore Cream, Pretat by TAT Balm Carbomer Free Gel, & All Naturally HL Hemorrhoid products due to manufacturing concerns at the facility

Ridge Properties DBA Pain Relief Naturally voluntarily recalls all lots within expiry of Naturally HL Bedsore Relief Cream, Extra Strength PreTAT by TAT Balm Carbomer Free Gel and Extra Strength Naturally HL Hemorrhoid Numbing with Lidocaine.


10/25/2017 12:24 PM
Know the Science of Complementary Health Approaches

This issue of NCCIH’s Clinical Digest discusses the newly launched “Know the Science” initiative to help consumers better understand complex scientific topics related to health research.


10/24/2017 02:46 PM
In Praise of Scientific Curiosity

Dr. Josephine Briggs, who recently stepped down as NCCIH Director, reflects on the NCCIH research portfolio and scientific curiosity.


10/19/2017 11:27 AM
NCCIH Introduces Know the Science Initiative

Science literacy efforts include interactive modules, videos to equip consumers for informed decision-making​​​​​​​

NCCIH launches “Know the Science”, an initiative designed to clarify and explain scientific topics related to health research.


10/17/2017 11:14 AM
U.S. District Court Rules in FTC’s Favor, Imposes $40 Million Judgment Against Weight-Loss Supplement Marketers for Order Violations

 A federal district judge in Atlanta has issued an order finding several defendants, including repeat offender Jared Wheat, in contempt for violating previous court orders related to the sale of weight-loss dietary supplements. The order imposes a more than $40 million judgment against the defendants, part or all of which the Federal Trade Commission may use to provide refunds to deceived consumers who bought the products.


10/17/2017 07:00 AM
Media Advisory: AAAS CEO Emeritus to present “Communicating Science to the Public: Follow the Science” on October 19

​​​​​​​What: Alan I. Leshner, Ph.D., CEO Emeritus of the American Association for the Advancement of Science, will give a lecture on science communication, touching upon needs for engaging with the public about science and lessons learned from communicating about complex topics.


10/12/2017 08:44 AM
Gadget Island, Inc. dba Gear Isle Issues Voluntary Nationwide Recall of Rhino 7 Platinum 5000, Papa Zen 3300, Fifty Shades 6000 and Grande X 5800, Due to Presence of Undeclared Sildenafil, Tadalafil and Desmethyl Carbodenafil

Newark, CA, Gadget Island, Inc. is voluntarily recalling Rhino 7 Platinum 5000 capsules, All LOTS, Papa Zen 3300 capsules, LOT# NSS050888, Fifty Shades 6000 capsules, all Lots, Grande X 5800 capsules, all Lots, to the consumer level. FDA analysis has found the products to be tainted with Sildenafil and Tadalafil, which are the active ingredients in two FDA-approved prescription drugs used for the treatment of erectile dysfunction (ED), as well as Desmethyl Carbodenafil which is structurally similar to sildenafil.


10/12/2017 08:42 AM
Kiriko, LLC. Issues Voluntary Nationwide Recall of A1 Slim Due to Undeclared Sibutramine, Phenolphthalein and N-Desmethyl sibutramine

Kiriko, LLC. is voluntarily recalling all lots of A1 Slim 30 capsules bottle to the consumer level.  FDA laboratory analysis has found the A1 Slim product to be tainted with sibutramine, phenolphthalein and N-Desmethyl sibutramine. 

These undeclared ingredients make this product an unapproved new drug for which safety and efficacy have not been established; therefore, subject to recall.